Global Market for Clinical Nutrition Pegged to Reach US$ 48.6B Value by 2020-End

(Newswire.net — June 30, 2017) New York City, New York — Apropos the recently-published report by Persistence Market Research, titled “Global Market Study on Clinical Nutrition,” the global market for clinical nutrition was valued at close to US$ 37 billion in 2013. The report projects that during an assessment period of 2014-2020, the global clinical nutrition market will soar at 4.1% CAGR, and will reach an estimated US$ 48.6 billion by the end of 2020.

A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/2812

Unlike regular nutrition, clinical nutrition provides consumers nutritional ingredients that are essential for a balanced functioning of physiological operations. These ingredients could include proteins, carbohydrates, fats, vitamins, minerals, and even water. Proper cellular functioning within a human body is vital for its existence, making clinical nutrition vital for every consumer in the world. Rising incidence of malnutrition-associated deaths recorded across the world is driving the demand for clinical nutrition. High birth rate, rising premature birth rate, and food scarcity are all directing towards higher consumption of clinical nutrition. Even developed countries are registering deaths due to imbalanced diets, which is why clinical nutrition products are important for consumers who have access to ample food but are not consuming essential ingredients in right amounts.

In 2012, over 30% of all hospitalized patients in Europe will be malnourished. Clinical nutrition is viewed as the most effective treatment for malnutrition. It is also the most affordable way of recovering from malnutrition. Countries such as China and India have high birth rates, which renders irregularities in proper food supply to individuals. Inconsistent availability of right nutrition to consumers in such developing countries is driving the demand for clinical nutrition.

According to the report, Asia-Pacific is the largest clinical nutrition market in the world. Primarily, increasing birth rate of APAC countries is instrumenting this rampant growth in their clinical nutrition markets. Growing geriatric population in this region is also contributing to higher consumption of clinical nutrition in Asia-Pacific. In North America, the clinical nutrition market is growing on the account of increasing consumer awareness about health benefits associated with clinical nutrition. Increasing healthcare costs in the U.S. are also driving the demand for clinical nutrition, which is relatively affordable. Europe’s clinical nutrition market, on the other hand, is growing due to high birth rates and rising population of aged consumers. 

View Report Table of Contents, Figures, and Tables @ http://www.persistencemarketresearch.com/market-research/clinical-nutrition-market/toc

The report comprehensively explains how the global clinical nutrition market reached a value of US$ 32.3 billion in 2010, and grew at 4.5% CAGR to reach US$ 36.9 billion value in 2013. Likewise, the report includes a regional breakdown, and highlights the growth of the Asia-Pacific clinical nutrition market, citing that it is likely to have soared at 4.8% CAGR to reach US$ 15.3 billion value by the end of 2013. In terms of competitive landscape, the global clinical nutrition market is highly concentrated – four major players are attributing to nearly 70% of global market share. Nestlé SA led this list in 2013, while other key market participants include Groupe Danone, Baxter International, Inc., B. Braun Melsungen AG, Abbott Laboratories, H. J. Heinz Company, Fresenius Kabi AG, Mead Johnson Nutrition Company, Hospira, Inc. and Perrigo Company Plc.